Latest Breaking News On - Dinko valerio - Page 1 : vimarsana.com

ProQR Therapeutics N : Annual General Meeting Results - Form 6-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private...

ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024

LEIDEN, Netherlands & CAMBRIDGE, Mass., April 23, 2024 -- ProQR Therapeutics NV. , a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™...

ProQR Therapeutics N : AGM 2024 Notice and Agenda

ProQR Therapeutics N : AGM 2024 Explanatory Notes

2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS PROQR THERAPEUTICS N.V. Explanatory Notes to the Agenda ProQR Therapeutics N.V. | Zernikedreef 9...

Xinvento Raises Seed Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Xinvento BV: Dutch biotech Xinvento raises seed round to develop a treatment for the rare disease Congenital Hyperinsulinism

AMSTERDAM, April 21, 2022 (GLOBE NEWSWIRE) -- Xinvento, a biotech company aiming to improve the lives of those with Congenital Hyperinsulinism, announces today the completion of a seed funding round. The

Dutch Biotech Xinvento Raises Seed Round to Develop Treatment for Congenital Hyperinsulinism

Leyden Laboratories Closes $140M Series B Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Leyden Labs unveils €40M for medicines that could prevent Covid-19 & more